Benign prostatic hyperplasia

Last updated: November 01, 2022

Benign prostatic hyperplasia

nclex

nclex

NCLEX Q&A with Jannah Amiel
Extrinsic hemolytic normocytic anemia: Pathology review
Heart blocks: Pathology review
Malabsorption syndromes: Pathology review
Dyslipidemias: Pathology review
Pituitary tumors: Pathology review
Pericardial disease: Pathology review
Multiple endocrine neoplasia: Pathology review
Peripheral artery disease: Pathology review
Theoretical Foundations of Nursing
Study for Success: Habits Every Nursing Student Should Adopt
Major depressive disorder
Bipolar and related disorders
Suicide
Schizophrenia
Delirium
Cluster C personality disorders
Cluster B personality disorders
Cannabis use disorder
Cocaine use disorder
Narcolepsy (NORD)
Mood disorders: Pathology review
Personality disorders: Pathology review
Drug misuse, intoxication and withdrawal: Hallucinogens: Pathology review
Eating disorders: Pathology review
Psychiatric emergencies: Pathology review
Amnesia, dissociative disorders and delirium: Pathology review
Serotonin and norepinephrine reuptake inhibitors
Atypical antipsychotics
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Fat-soluble vitamin deficiency and toxicity: Pathology review
Huntington disease
Cri du chat syndrome
Marfan syndrome
Sickle cell disease (NORD)
Myocardial infarction
Peripheral artery disease
Hypertension
Tetralogy of Fallot
Heart failure
Myocarditis
Atherosclerosis and arteriosclerosis: Pathology review
Shock: Pathology review
Diabetes mellitus
Diabetic nephropathy
Diabetes insipidus and SIADH: Pathology review
Sleep apnea
Celiac disease
Crohn disease
Ulcerative colitis
Bowel obstruction
Jaundice
Neonatal hepatitis
Iron deficiency anemia
Chronic leukemia
Coagulation disorders: Pathology review
Anaphylaxis
Asthma
Candida
Osteomyelitis
Osteoarthritis
Scleroderma
Epidural hematoma
Shaken baby syndrome
Seizures and epilepsy
Frontotemporal dementia
Multiple sclerosis
Guillain-Barre syndrome
Seizures: Pathology review
Hypermagnesemia
Hypercalcemia
Hyponatremia
Chronic kidney disease
Electrolyte disturbances: Pathology review
Benign prostatic hyperplasia
Placenta previa
Placental abruption
Gestational diabetes
Gestational hypertension
Postpartum hemorrhage
Miscarriage
Sudden infant death syndrome
Acute respiratory distress syndrome
Pulmonary embolism
Pharmacokinetics: Drug elimination and clearance
Drug administration and dosing regimens
Cholinomimetics: Direct agonists
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Beta blockers
ACE inhibitors, ARBs and direct renin inhibitors
Class III antiarrhythmics: Potassium channel blockers
Lipid-lowering medications: Statins
Insulins
Anticoagulants: Heparin
Anticoagulants: Warfarin
Glucocorticoids
Sympathomimetics: Direct agonists
Neuromuscular blockers
Uterine stimulants and relaxants
Medication overdoses and toxicities: Pathology review
Normal heart sounds
Oxytocin and prolactin
Thyroid hormones
Insulin
Synthesis of adrenocortical hormones
Phosphate, calcium and magnesium homeostasis
Erythropoietin
Respiratory acidosis
Metabolic acidosis
Pregnancy
Breastfeeding
Pulmonary shunts
Renin-angiotensin-aldosterone system
Calcium channel blockers
Thiazide and thiazide-like diuretics
Positive inotropic medications
Lipid-lowering medications: Fibrates
Antidiuretic hormone
Hypoglycemics: Insulin secretagogues
Acid reducing medications
Pyloric stenosis
Graft-versus-host disease
Myasthenia gravis
Autoimmune hemolytic anemia
Food allergy
Vaccinations
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Febrile seizure
Brain herniation
Muscarinic antagonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Nonbenzodiazepine anticonvulsants
Opioid antagonists
Acid-base map and compensatory mechanisms
Metabolic alkalosis
Ventilation-perfusion ratios and V/Q mismatch
Emphysema
Respiratory alkalosis
Diabetes insipidus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Pharmacokinetics: Drug absorption and distribution
Adrenergic antagonists: Presynaptic
Selective serotonin reuptake inhibitors
Atypical antidepressants
Cell wall synthesis inhibitors: Penicillins
Hepatitis medications
Migraine medications
Osmotic diuretics
Androgens and antiandrogens
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Puberty and Tanner staging
Carbon dioxide transport in blood

Transcript

Watch video only

In benign prostatic hyperplasia, or BPH, prostatic refers to the prostate gland, hyperplasia means an increase in the number of cells, and benign means that these cells aren’t malignant, so they don’t invade neighboring tissues.

So, benign prostatic hyperplasia is the non-cancerous growth of the prostate gland.

This condition is common in men over 50, and is often considered a normal part of aging.

The prostate is a small gland, about the size and shape of a walnut, that sits under the bladder and in front of the rectum.

The urethra which is the tube through which urine leaves the bladder, goes through the prostate before reaching the penis.

And that part of the urethra is called the prostatic urethra.

The prostate is covered by a capsule of tough connective tissue and smooth muscle.

Beneath this layer, the prostate can be divided into a few zones.

The peripheral zone, which is the outermost posterior section, is the largest of the zone and contain about 70% of the prostate’s glandular tissue.

Moving inward, the next section is the central zone which contains about 25% of the glandular tissue as well as the ejaculatory ducts that join with the prostatic urethra.

Last, is the transitional zone, which contains around 5% of the glandular tissue as well as a portion of the prostatic urethra.

The transitional zone gets its name because it contains transitional cells which are also found in the bladder.

At the microscopic level, each of the tiny glands that make up the prostate is surrounded by a basement membrane made largely of collagen.

Sitting within that basement membrane, is a ring of cube-shaped basal cells as well as a few neuroendocrine cells interspersed throughout.

Finally, there’s an inner ring of luminal columnar cells, which are within the lumen or center of the gland. Luminal cells secrete substances into the prostatic fluid, that make it slightly alkaline that give it nutrients which nourish the sperm and help it survive in the acidic environment of the vagina.

During an ejaculation, sperm leave the testes, travel through the vas deferens, into the ejaculatory ducts, and travel through the prostatic urethra.

Smooth muscles in the prostate contract and push the prostatic fluid into the urethra where it joins the sperm as well as the semen which is the fluid that comes from the seminal vesicles.

The luminal cells also produce prostate specific antigen, or PSA, which helps to liquefy the gel-like semen after ejaculation, thereby freeing the sperm to swim.

The basal cells and luminal cells of the prostate rely on stimulation from androgens, or male sex hormones, for survival.

The androgens include testosterone, which is produced by the testicles, and dihydrotestosterone, which is produced in the prostate itself.

This androgen is produced by the prostatic enzyme 5α-reductase which converts testosterone into the more potent dihydrotestosterone.

Since androgens are steroids, so they can cross the cell membrane and bind to the androgen receptors within the cell’s nucleus.

This inhibits the apoptosis of or programmed cell death, allowing luminal and basal cells in the prostate to keep growing and multiplying.

Dihydrotestosterone is ten times more potent than testosterone because it can bind to androgen receptors much longer.

Now, after the age of 30, men produce about 1% less testosterone per year.

But for unclear reasons, 5α-reductase activity increases with age, so even with less testosterone, there could be an increase in dihydrotestosterone.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine 20th Ed" McGraw Hill / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine, 8e" McGraw Hill (2019)
  4. "Current Medical Diagnosis and Treatment 2020" McGraw Hill (2020)
  5. "Management of Benign Prostatic Hyperplasia" Annual Review of Medicine (2016)
  6. "Post-micturition dribble in men: causes and treatment" Nursing Standard (2008)
  7. "Post-micturition dribble in men: causes and treatment" Nursing Standard (2008)